Post-Exertional Malaise
717 studies in the atlas
Post-exertional malaise (PEM) is the defining feature of myalgic encephalomyelitis/chronic fatigue syndrome — a disproportionate worsening of symptoms following physical, cognitive, or emotional exertion, typically delayed by 12 to 72 hours. PEM is required for diagnosis by the Canadian Consensus Criteria, International Consensus Criteria, and IOM 2015 criteria. Two-day cardiopulmonary exercise testing (CPET) reveals a reproducible decline in exercise capacity on the second test day — a pattern not seen in deconditioning or other fatiguing conditions, and consistent with but not yet proven to be the direct mechanism of PEM. Research into PEM mechanisms explores immune activation, signals suggestive of impaired cellular energy production, autonomic abnormalities, and ion channel findings in immune cells under physiological stress; no single mechanism has been established as causal.
What we know
- Two-day CPET reveals a reproducible decline in exercise capacity on day 2 in ME/CFS patients, a pattern not seen in sedentary controls or other fatiguing conditions
- PEM is required by all current major diagnostic criteria (CCC 2003, ICC 2011, IOM 2015)
- Onset is typically delayed, most commonly 12–72 hours after exertion
- Both physical and cognitive exertion can trigger PEM
- The day-2 CPET decline is one of the more objective physiological correlates of PEM reported in the literature, though the mechanistic link between exercise-capacity decline and symptom exacerbation is not fully established
What remains uncertain
- Immune activation during or after exertion may contribute to PEM through inflammatory pathways
- Impaired cellular energy metabolism may play a role in the post-exertional crash
- Ion channel dysfunction in immune cells has been observed under experimental stress conditions and may be relevant
- Heart rate monitoring may help some patients identify individual exertion thresholds, though evidence is still limited
- NK cell function, already reduced at baseline, may worsen further after exertion
What is emerging
- The precise biological mechanism that produces PEM
- Why the delay between exertion and symptom onset varies between patients and episodes
- Whether PEM is driven by a single pathway or multiple converging mechanisms
- How to reliably interrupt or reverse a PEM episode once it has begun
- Whether early and consistent pacing can prevent long-term disease progression
- Whether pharmacological intervention can meaningfully raise the PEM threshold
Start here
Dysregulation of lipid metabolism, energy production, and oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome, Gulf War Syndrome and fibromyalgia.
Davis, Leah, Higgs, Maisy, Snaith, Ailsa et al.·Frontiers in neuroscience·2025
This review examined research showing that ME/CFS, Gulf War Syndrome, and fibromyalgia may share similar problems with how the body produces energy and handles stress at the cellular level. Scientists found that these three conditions show signs of disrupted fat metabolism, energy production difficulties, and increased cellular damage from oxidative stress. Better understanding these shared biological problems could help doctors diagnose these conditions faster and develop treatments that target the root causes rather than just treating symptoms.
Research Momentum
717 publications over 38 years. Recent trend: steady (67/year over the last 3 years).
Top Studies
60 of 717, sorted by review status and evidence level
Insights into the Complex Biological Network Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
2025 · ModerateThe search for a blood-based biomarker for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS): from biochemistry to electrophysiology.
2025 · PreliminaryGut Microbiome and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Insights into Disease Mechanisms.
2025 · ModerateRecent research in myalgic encephalomyelitis/chronic fatigue syndrome: an evidence map.
2025 · ModerateUnravelling the Connection Between Energy Metabolism and Immune Senescence/Exhaustion in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
2025 · Preliminary[Interdisciplinary, collaborative D-A-CH (Germany, Austria and Switzerland) consensus statement concerning the diagnostic and treatment of myalgic encephalomyelitis/chronic fatigue syndrome].
2024 · ModerateAdvancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives.
2024 · ModerateDoes the effect of cognitive behavior therapy for chronic fatigue syndrome (ME/CFS) vary by patient characteristics? A systematic review and individual patient data meta-analysis.
2024 · HigherExercise therapy for chronic fatigue syndrome.
2024 · ModerateChronic Fatigue Syndrome: Diagnosis, Treatment, and Future Direction.
2024 · ModerateQigong and Tai Chi for ME/CFS: A Systematic Review of Randomized Controlled Trials.
2024 · Preliminary[Tiredness/Fatigue-S3 guideline update].
2023 · ModerateThe Draft Report by the Institute for Quality and Efficiency in Healthcare Does Not Provide Any Evidence That Graded Exercise Therapy and Cognitive Behavioral Therapy Are Safe and Effective Treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
2023 · WeakWhat Primary Care Practitioners Need to Know about the New NICE Guideline for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Adults.
2022 · HigherThe underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome.
2022 · ModerateThe Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME/CFS.
2022 · ModerateA Comprehensive Update of the Current Understanding of Chronic Fatigue Syndrome.
2021 · ModerateMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
2021 · ModerateMyalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?
2021 · ModerateThe Safety of Baduanjin Exercise: A Systematic Review.
2021 · PreliminaryThe evidence base for physiotherapy in myalgic encephalomyelitis/chronic fatigue syndrome when considering post-exertional malaise: a systematic review and narrative synthesis.
2021 · ModerateThe Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications.
2021 · ModerateReview of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
2020 · HigherThe Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis.
2020 · ModerateGraded exercise therapy does not restore the ability to work in ME/CFS - Rethinking of a Cochrane review.
2020 · ModerateEnvironmental, Neuro-immune, and Neuro-oxidative Stress Interactions in Chronic Fatigue Syndrome.
2020 · ModerateMeta-analysis investigating post-exertional malaise between patients and controls.
2020 · HigherChronotropic Intolerance: An Overlooked Determinant of Symptoms and Activity Limitation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
2019 · ModeratePeak Oxygen Uptake in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Meta-Analysis.
2019 · Higher[Myalgic encephalomyelitis or chronic fatigue syndrome].
2019 · ModeratePathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
2019 · ModerateExercise therapy for chronic fatigue syndrome.
2019 · ModerateGraded exercise therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective and unsafe. Re-analysis of a Cochrane review.
2018 · Moderate[Neurologic Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review].
2018 · ModerateEffect of Acute Exercise on Fatigue in People with ME/CFS/SEID: A Meta-analysis.
2016 · PreliminaryChronic fatigue syndrome and circulating cytokines: A systematic review.
2015 · PreliminaryBeyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness
2015 · HigherDiagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
2014 · ModerateAltered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review.
2014 · ModerateIn the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome.
2012 · ModerateChronic fatigue syndrome: diagnosis and treatment.
2012 · ModeratePacing as a strategy to improve energy management in myalgic encephalomyelitis/chronic fatigue syndrome: a consensus document.
2012 · Moderate[Exercise therapy for patients with chronic fatigue syndrome].
2011 · ModerateTired of being inactive: a systematic literature review of physical activity, physiological exercise capacity and muscle strength in patients with chronic fatigue syndrome.
2011 · ModerateA review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS.
2009 · ModerateThe chronic fatigue syndrome--an update.
2007 · ModerateChronic musculoskeletal pain in patients with the chronic fatigue syndrome: a systematic review.
2007 · ModerateChronic musculoskeletal pain in chronic fatigue syndrome: recent developments and therapeutic implications.
2006 · ModerateA status report on chronic fatigue syndrome.
2002 · PreliminaryClinical practice guideline for long COVID prevention and treatment.
2026 · PreliminaryRecommended long COVID outcome measures and their implications for clinical trial design, with a focus on post-exertional malaise.
2026 · ModerateCOVID-19-associated neurological and psychological manifestations.
2025 · ModerateDeveloping effective strategies to optimize physical activity and cardiorespiratory fitness in the long Covid population- The need for caution and objective assessment.
2024 · ModerateLong COVID: Long-Term Impact of SARS-CoV2.
2024 · ModeratePrevalence and measurement of post-exertional malaise in post-acute COVID-19 syndrome: A systematic review and meta-analysis.
2024 · ModeratePost-Acute Sequelae of SARS-CoV-2 Infection and Its Impact on Adolescents and Young Adults.
2024 · ModerateExcess risks of long COVID symptoms compared with identical symptoms in the general population: A systematic review and meta-analysis of studies with control groups.
2024 · HigherA review of Patient Reported Outcome Measures (PROMs) for characterizing Long COVID (LC)-merits, gaps, and recommendations.
2024 · ModerateCognitive dysfunction in post-COVID-19 condition: Mechanisms, management, and rehabilitation.
2023 · ModerateContribute
Private, reviewed by a human. Not a public comment thread.